[1]
Lin XD, He JJ, Lin F, Chen HZ, Xu LQ, Hu W, Cai NQ, Lin MT, Wang N, Wang ZQ, Xu GR. A "Triple Trouble" Case of Facioscapulohumeral Muscular Dystrophy Accompanied by Peripheral Neuropathy and Myoclonic Epilepsy. Chinese medical journal. 2018 Sep 20:131(18):2164-2171. doi: 10.4103/0366-6999.240797. Epub
[PubMed PMID: 30203790]
[2]
Banerji CR, Knopp P, Moyle LA, Severini S, Orrell RW, Teschendorff AE, Zammit PS. β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy. Journal of the Royal Society, Interface. 2015 Jan 6:12(102):20140797
[PubMed PMID: 25551153]
[3]
van der Maarel SM, Frants RR. The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. American journal of human genetics. 2005 Mar:76(3):375-86
[PubMed PMID: 15674778]
[4]
Statland JM, Tawil R. Facioscapulohumeral Muscular Dystrophy. Continuum (Minneapolis, Minn.). 2016 Dec:22(6, Muscle and Neuromuscular Junction Disorders):1916-1931
[PubMed PMID: 27922500]
[5]
Dumbovic G, Forcales SV, Perucho M. Emerging roles of macrosatellite repeats in genome organization and disease development. Epigenetics. 2017 Jul 3:12(7):515-526. doi: 10.1080/15592294.2017.1318235. Epub 2017 Apr 20
[PubMed PMID: 28426282]
[6]
Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V. Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 2014:43(3-4):259-68. doi: 10.1159/000369343. Epub 2014 Dec 16
[PubMed PMID: 25532075]
Level 1 (high-level) evidence
[7]
Orrell RW. Facioscapulohumeral dystrophy and scapuloperoneal syndromes. Handbook of clinical neurology. 2011:101():167-80. doi: 10.1016/B978-0-08-045031-5.00013-X. Epub
[PubMed PMID: 21496633]
[8]
Ricci G, Zatz M, Tupler R. Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears. Current molecular medicine. 2014:14(8):1052-1068. doi: 10.2174/1566524014666141010155054. Epub
[PubMed PMID: 25323867]
[9]
Tasca G, Pescatori M, Monforte M, Mirabella M, Iannaccone E, Frusciante R, Cubeddu T, Laschena F, Ottaviani P, Ricci E. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PloS one. 2012:7(6):e38779. doi: 10.1371/journal.pone.0038779. Epub 2012 Jun 13
[PubMed PMID: 22719944]
[10]
Statland JM, Shah B, Henderson D, Van Der Maarel S, Tapscott SJ, Tawil R. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies. Muscle & nerve. 2015 Oct:52(4):521-6. doi: 10.1002/mus.24621. Epub 2015 Jun 18
[PubMed PMID: 25704033]
[11]
Bankolé LC, Millet GY, Temesi J, Bachasson D, Ravelojaona M, Wuyam B, Verges S, Ponsot E, Antoine JC, Kadi F, Féasson L. Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: A randomized controlled trial. Medicine. 2016 Aug:95(31):e4497. doi: 10.1097/MD.0000000000004497. Epub
[PubMed PMID: 27495097]
Level 1 (high-level) evidence
[12]
Lu J, Yao Z, Yang Y, Zhang C, Zhang J, Zhang Y. Management strategies in facioscapulohumeral muscular dystrophy. Intractable & rare diseases research. 2019 Feb:8(1):9-13. doi: 10.5582/irdr.2019.01016. Epub
[PubMed PMID: 30881851]
[13]
Orrell RW, Copeland S, Rose MR. Scapular fixation in muscular dystrophy. The Cochrane database of systematic reviews. 2010 Jan 20:2010(1):CD003278. doi: 10.1002/14651858.CD003278.pub2. Epub 2010 Jan 20
[PubMed PMID: 20091543]
Level 1 (high-level) evidence
[14]
Tawil R, van der Maarel S, Padberg GW, van Engelen BG. 171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscular disorders : NMD. 2010 Jul:20(7):471-5. doi: 10.1016/j.nmd.2010.04.007. Epub
[PubMed PMID: 20554202]
[15]
Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, Preston MK, Tawil R, Wang LH. Facioscapulohumeral Muscular Dystrophy. GeneReviews(®). 1993:():
[PubMed PMID: 20301616]
[16]
Morís G, Wood L, FernáNdez-Torrón R, González Coraspe JA, Turner C, Hilton-Jones D, Norwood F, Willis T, Parton M, Rogers M, Hammans S, Roberts M, Househam E, Williams M, Lochmüller H, Evangelista T. Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy. Muscle & nerve. 2018 Mar:57(3):380-387. doi: 10.1002/mus.25991. Epub 2017 Nov 7
[PubMed PMID: 29053898]
Level 2 (mid-level) evidence
[17]
Henke C, Spiesshoefer J, Kabitz HJ, Herkenrath S, Randerath W, Brix T, Görlich D, Young P, Boentert M. Respiratory muscle weakness in facioscapulohumeral muscular dystrophy. Muscle & nerve. 2019 Dec:60(6):679-686. doi: 10.1002/mus.26717. Epub 2019 Oct 23
[PubMed PMID: 31566774]
[18]
Mul K, Berggren KN, Sills MY, McCalley A, van Engelen BGM, Johnson NE, Statland JM. Effects of weakness of orofacial muscles on swallowing and communication in FSHD. Neurology. 2019 Feb 26:92(9):e957-e963. doi: 10.1212/WNL.0000000000007013. Epub 2019 Jan 25
[PubMed PMID: 30804066]
[19]
Nieto R, Raichle KA, Jensen MP, Miró J. Changes in pain-related beliefs, coping, and catastrophizing predict changes in pain intensity, pain interference, and psychological functioning in individuals with myotonic muscular dystrophy and facioscapulohumeral dystrophy. The Clinical journal of pain. 2012 Jan:28(1):47-54. doi: 10.1097/AJP.0b013e31822019b1. Epub
[PubMed PMID: 21642844]
[20]
McGregor J, Mercer SW, Harris FM. Health benefits of primary care social work for adults with complex health and social needs: a systematic review. Health & social care in the community. 2018 Jan:26(1):1-13. doi: 10.1111/hsc.12337. Epub 2016 Apr 5
[PubMed PMID: 27059167]
Level 1 (high-level) evidence
[21]
Zhou L, Parmanto B. Reaching People With Disabilities in Underserved Areas Through Digital Interventions: Systematic Review. Journal of medical Internet research. 2019 Oct 25:21(10):e12981. doi: 10.2196/12981. Epub 2019 Oct 25
[PubMed PMID: 31654569]
Level 1 (high-level) evidence